“…In the United States, health insurance status is highly associated with cancer-screening participation and the stage of disease at the time of diagnosis (Ayanian, Kohler, Abe, et al 1993;Catalano and Satariano 1998;Lannin, Mathews, Mitchell, et al 1998;Parker, Gebretsadik, Sabogal, et al 1998;Potosky, Breen, Graubard, et al 1998;Eisen, Waterman, Skinner, et al 1999;Lewis and Asch 1999), and also with access to the best available treatments (Greenberg, Chute, Stukel, et al 1988;Hadley, Steinberg, and Feder 1991;Mitchell, Meehan, Kong, et al 1997;McKinlay, Burns, Durante, et al 1997;Bennett, Stinson, Yang, et al 1999). Rate ratios generally range from 1.50 to 2.50, basically indicative of twofold greater access among those with more generous insurance payers.…”